Loading...
Thymosin α1 protects from CTLA-4 intestinal immunopathology
The advent of immune checkpoint inhibitors has represented a major boost in cancer therapy, but safety concerns are increasingly being recognized. Indeed, although beneficial at the tumor site, unlocking a safeguard mechanism of the immune response may trigger autoimmune-like effects at the peripher...
Na minha lista:
| Udgivet i: | Life Sci Alliance |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Life Science Alliance LLC
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7441522/ https://ncbi.nlm.nih.gov/pubmed/32817121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.26508/lsa.202000662 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|